IPP Bureau
Green ChemisTree Foundation announces virtual conference on Innovations in Green & Sustainable Chemistry for Pharma Industry
By IPP Bureau - December 30, 2021
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA
By IPP Bureau - December 30, 2021
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Granules receives ANDA approval for amphetamine mixed salts
By IPP Bureau - December 30, 2021
The current annual U.S. market for amphetamine mixed salts, USP 1.25mg, 1.875mg, 2.5mg, 3.125mg, 3.75mg, 5mg, 7.5mg immediate release tablets strengths is approximately US $ 335 million, according to MAT, Oct 2021 IQVIA/IMS Health
Siemens Healthineers receive EUA for Covid-19 antigen self-test
By IPP Bureau - December 30, 2021
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Sanofi loses appeal in the US over Lantus device patents
By IPP Bureau - December 30, 2021
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
Study demonstrates Covaxin safe for kids in the age 2-18 years
By IPP Bureau - December 30, 2021
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
Translumina to set up Asia's largest heart valve facility at AMTZ Vizag
By IPP Bureau - December 29, 2021
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
U.S. FDA approves Leo Pharma’s Adbry
By IPP Bureau - December 29, 2021
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
Crysta IVF launches centre in Mumbai
By IPP Bureau - December 29, 2021
The newly launched centre in Mumbai is part of the company’s ambition to be present in 100 cities across the country within two years.”
JB Chemicals and Pharmaceuticals to launch molnupiravir next month
By IPP Bureau - December 29, 2021
It will be marketed under the brand name Molunamax
G42 Healthcare, Abu Dhabi and AstraZeneca to collaborate on clinical research
By IPP Bureau - December 29, 2021
G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE
CDSCO expert committee recommends Emergency Use Authorisation to Covovax and Corbevax
By IPP Bureau - December 28, 2021
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
RaphaCure partners with Zeebon for foraying into North East market
By IPP Bureau - December 28, 2021
Zeebon is the largest diagnostics services provider in North-Eastern states
Granules Inc., receives ANDA approval for prazosin hydrochloride
By IPP Bureau - December 28, 2021
The current annual U.S. market for prazosin hydrochloride 1mg, 2mg, 5mg strengths is approximately US $ 54 million, according to IQVIA/IMS Health
Trastuzumab deruxtecan type II variation application validated by EMA
By IPP Bureau - December 28, 2021
Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1)
